A M Neville
Overview
Explore the profile of A M Neville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
1894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaffe T, Neville A, Bashir M, Uronis H, Thacker J
Colorectal Dis
. 2013 Aug;
15(11):e654-8.
PMID: 23910050
Aim: Patients with rectal cancer often undergo multiple CT scans prior to surgical resection. We propose that in patients with locally advanced rectal cancer without evidence of metastatic disease at...
2.
Reiner C, Neville A, Nazeer H, Breault S, Dale B, Merkle E, et al.
Eur Radiol
. 2013 Jun;
23(11):3087-93.
PMID: 23732689
Objective: Evaluate the image quality and diagnostic performance of a free-breathing 3D-gradient-echo sequence with radial acquisition (rGRE) compared with a Cartesian breath-hold 3D-GRE (cGRE) sequence on hepatobiliary phase MRI in...
3.
Curigliano G, Viale G, Ghioni M, Jungbluth A, Bagnardi V, Spagnoli G, et al.
Ann Oncol
. 2010 Jul;
22(1):98-103.
PMID: 20610479
Background: cancer-testis (CT) antigens, frequently expressed in human germline cells but not in somatic tissues, may become aberrantly reexpressed in different cancer types. The aim of this study was to...
4.
Smith M, Neville A, Middleton J
Intern Med J
. 2003 Sep;
33(9-10):414-9.
PMID: 14511193
Background: The Heart Outcomes Prevention Evaluation (HOPE) study has demonstrated that ramipril 10 mg/day for 5 years in an at-risk population results in clinically and statistically significant reductions in the...
5.
Hawes D, Neville A, Cote R
Semin Surg Oncol
. 2001 Dec;
20(4):312-8.
PMID: 11747273
The most important factor affecting the outcome of patients with invasive cancer is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of...
6.
Hawes D, Neville A, Cote R
Ann Surg Oncol
. 2001 Oct;
8(9 Suppl):60S-63S.
PMID: 11599903
The presence of occult metastases in the lymph nodes, bone marrow, or both of these compartments may not only define patients who are at higher risk for recurrence and death...
7.
Hawes D, Neville A, Cote R
Biomed Pharmacother
. 2001 Jun;
55(4):229-42.
PMID: 11393810
The most important factor affecting the outcome of patients with invasive cancers is whether the tumor has spread, either regionally (to regional lymph nodes) or systemically. However, a proportion of...
8.
OHare M, Bond J, Clarke C, Takeuchi Y, Atherton A, Berry C, et al.
Proc Natl Acad Sci U S A
. 2001 Feb;
98(2):646-51.
PMID: 11209060
Reports differ as to whether reconstitution of telomerase activity alone is sufficient for immortalization of different types of human somatic cells or whether additional activities encoded by other "immortalizing" genes...
9.
Liu D, Baltayan A, Naritoku W, Barr N, Young L, Chaiwun B, et al.
Anticancer Res
. 2000 Aug;
20(3A):1451-61.
PMID: 10928056
The purpose of this retrospective study was to examine the prognostic value of expression of luminal epithelial antigen (LEA.135) for recurrence and overall survival of patients with primary invasive breast...
10.
Cote R, Peterson H, Chaiwun B, Gelber R, Goldhirsch A, Castiglione-Gertsch M, et al.
Lancet
. 1999 Sep;
354(9182):896-900.
PMID: 10489948
Background: This study was designed to ascertain whether immunohistochemical methods could improve the detection of metastases in primary breast-cancer patients whose axillary lymph nodes were classified, by conventional methods, as...